Skip to content

Welcome to Discover Pharma! Today is : October 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CDMO

  • Advanced Therapies,Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome

    Andelyn Biosciences is manufacturing Ultragenyx’s newly FDA-approved Fayuvi gene therapy [...]

    September 21, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development

    Centrix and University of Sussex launch £375,000 data science project for drug development

    Centrix Pharma Solutions and the University of Sussex are using [...]

    August 26, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development

    Lonza launches rapid custom media service for early bioprocess development

    Lonza has launched a custom media prototyping service designed to [...]

    August 24, 2026
  • Manufacturing & Supply Chain

    University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing

    University Hospital Cologne has selected Celonic as its CDMO partner [...]

    August 13, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development

    Piramal Pharma Solutions expands peptide API facility with spray drying suite

    Piramal Pharma Solutions has expanded its dedicated peptide development and [...]

    August 4, 2026
  • Clinical & Regulatory,Manufacturing & Supply Chain

    Pace Life Sciences passes FDA inspection at North Carolina facility

    Pace Life Sciences has completed a US FDA inspection of [...]

    July 27, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Lonza expands ADC drug product capacity in Switzerland

    Lonza is expanding its commercial-scale aseptic drug product capacity in [...]

    July 23, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development

    Samsung Biologics to acquire PolyPeptide in $1.46bn deal

    Samsung Biologics has announced plans to acquire peptide CDMO PolyPeptide [...]

    July 21, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Evonik invests $100M to expand US drug substance manufacturing

    Evonik is investing US$100 million over the next five years [...]

    July 9, 2026
  • Advanced Therapies,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Lonza expands HPAPI capacity to support ADC manufacturing

    Lonza will expand its highly potent active pharmaceutical ingredient manufacturing [...]

    July 2, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Johnson & Johnson reports three-year Crohn’s disease results for guselkumab
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Ryvu reports preclinical results for novel ADC payload
    Categories: Drug Discovery & Development, Research & Development
  • Kindeva wins $226 million contract for nerve agent antidote autoinjectors
    Categories: Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top